Sandu Pharmaceuticals Ltd
Ticker: SANDUPHQ
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
44.09
Market Cap
42.60
Debt/Equity
0.0000
ROE %
3.753
PB
1.0137
Promoter %
42.902
Pledge %
0.000
1Y Rev Growth %
-0.502
5Y Rev Growth %
NP Margin %
2.301
NP Margin 5Y Avg %
Trading Reference
1M Return %
-6.454
6M Return %
-10.204
1Y Return %
-25.949
% Away 52W High
47.086
% Away 52W Low
2.226
Daily Volume
2176
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Sandu Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level at ₹X, it could see an upside of approximately 15%. However, if it falls below the support level, there is a potential downside of around 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Acrow India Ltd
Acrow India Ltd presents a mixed investment case with some strengths in its business model but significant risks in growth consistency and market sentiment.
View details
P
Picturepost Studios Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
View details
S
Sai Swami Metals and Alloys Ltd
Sai Swami Metals and Alloys Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
N
Nippon India Nifty Pharma ETF
The Nippon India Nifty Pharma ETF shows potential in a growing sector but faces challenges in profitability and execution risks. It's a decent option for cautious investors.
View details
L
Lerthai Finance Ltd
Lerthai Finance Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
S
Shree Rajasthan Syntex Ltd
Shree Rajasthan Syntex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
D
Danube Industries Ltd
Danube Industries Ltd shows potential but faces challenges in profitability and valuation metrics.
View details
V
Viji Finance Ltd
Viji Finance Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
H
Hybrid Financial Services Ltd
Hybrid Financial Services Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
K
Kaushalya Infrastructure Development Corporation Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
H
Hawa Engineers Ltd
Hawa Engineers Ltd shows potential in a growing sector, but faces significant challenges in growth consistency, profitability, and valuation, making it a risky investment at this time.
View details
R
Ranjeet Mechatronics Ltd
Ranjeet Mechatronics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dindigul Farm Product Ltd
Dindigul Farm Product Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Soni Medicare Ltd
Soni Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SVP Global Textiles Ltd
SVP Global Textiles Ltd faces significant challenges in growth and profitability, with risks outweighing potential rewards.
View details
P
PVV Infra Ltd
PVV Infra Ltd shows potential in a critical sector, but faces challenges in growth consistency and profitability metrics.
View details
Business Overview
Sandu Pharmaceuticals Ltd is a trusted name in the Indian healthcare sector, specializing in Ayurvedic and herbal products. Catering to health-conscious consumers, the company focuses on delivering high-quality solutions that promote holistic well-being. With a commitment to traditional practices and modern science, Sandu stands out for its efficacy and reliability. Its extensive product range addresses various health needs, making it a go-to choice for families seeking natural remedies.
- Established leader in Ayurvedic healthcare
- Wide range of herbal products
- Focus on quality and efficacy
- Trusted by families across India
- Commitment to traditional and modern practices
Investment Thesis
Sandu Pharmaceuticals Ltd offers a compelling investment opportunity due to its strong promoter credibility, significant growth in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth in the competitive pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Rapid growth in digital services presents a lucrative revenue stream.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust product portfolio supports long-term market presence.
- Strategic initiatives align with evolving healthcare trends, ensuring relevance.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong product pipeline
- Rising online sales channels
Risks ⚠️
- Regulatory challenges in pharmaceuticals
- Intense competition in the sector
- Dependency on few key products
- Fluctuating raw material prices
Peer Perspective
Sandu Pharmaceuticals Ltd trades at a discount to peers like Cipla and Sun Pharma, primarily due to margin volatility. A stable margin and consistent growth could trigger a rerating, aligning it closer to industry averages.
Future Outlook
Sandu Pharmaceuticals Ltd is well-positioned for growth, driven by expanding product lines and market reach; however, successful execution and cost control will be crucial to fully realize its potential in the coming years.
AI FAQs for Retail Users
- Q: What does Sandu Pharmaceuticals Ltd do?A: Sandu Pharmaceuticals Ltd is involved in manufacturing and selling pharmaceutical products and herbal medicines.
- Q: Is Sandu Pharmaceuticals Ltd listed on Indian stock exchanges?A: Yes, Sandu Pharmaceuticals Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What factors can affect Sandu Pharmaceuticals' stock price?A: Factors include company performance, market conditions, regulatory changes, and overall economic environment.
- Q: How can I invest in Sandu Pharmaceuticals Ltd?A: You can invest by purchasing shares through a registered stockbroker or online trading platform.
- Q: What is the dividend policy of Sandu Pharmaceuticals Ltd?A: Dividend policies can vary; check the company's announcements for the latest information on dividends.
📊 Stock Investment Checklist (100 Points)
Sandu Pharmaceuticals Ltd • Updated: 2025-09-18 07:29:22
-
10BusinessHighPharmaceutical sector is essential, but competition is high.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Sandu Pharmaceuticals has a decent growth outlook but faces challenges in valuation and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100